Sir David Lane, FRS, is a British immunologist, molecular biologist and cancer researcher. He is best known for the discovery of p53, one of the most important tumour suppressor genes. He is currently Scientific Director of Ludwig Cancer Research, Chief Scientist of the Agency for Science, Technology and Research (A*STAR) in Singapore, and Chairman of Chugai Pharmabody.
He has been recognized by many awards including the Joseph Steiner Prize, the Meyenburg Prize, the Yvette Mayent Prize, the Paul Ehrlich Prize and the Cancer Research UK Lifetime Achievement Prize. He has been awarded honorary degrees from the Universities of Toulouse, Birmingham, Aberdeen, Stirling, Abertay and Nottingham. He has also been recognized for his business acumen with the award of Emerging Entrepreneur of the year.